Ischemic Stroke Clinical Trials in Cincinnati, Ohio

5 studies are recruiting for ischemic stroke in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

    The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Cincinnati, Cincinnati, Ohio
    Locations
    31 in total
    Run by
    Massachusetts General Hospital

    See if you can join NCT04916210 on ClinicalTrials.gov

  2. K01 Impacts of Lingual Endurance Exercise

    The goal of this clinical trial is to learn whether a tongue endurance exercise program can improve swallowing function in adults with dysphagia after a stroke. It also aims to explore how this exercise may affect brain structure and connectivity involved in swallowing. The main questions it aims t…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Cincinnati, Cincinnati, Ohio
    Run by
    University of Cincinnati

    See if you can join NCT06072924 on ClinicalTrials.gov

  3. Post-Stroke Sensory Reweighting on Walking and Balance Outcomes

    The primary objective of this proof-of-concept study is to longitudinally track the development of post-stroke sensory reweighting (PSR), identify associated structural neuroanatomical correlates, and investigate their relationship to walking and fall outcomes.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Cincinnati College of Medicine, Cincinnati, Ohio
    Run by
    University of Cincinnati

    See if you can join NCT06727097 on ClinicalTrials.gov

  4. Strategy for Improving Stroke Treatment Response

    SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Cincinnati Medical Center, Cincinnati, Ohio
    Locations
    52 in total
    Run by
    Translational Sciences, Inc.

    See if you can join NCT05948566 on ClinicalTrials.gov

  5. StrokeNet Thrombectomy Endovascular Platform

    STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Cincinnati Medical Center, Cincinnati, Ohio
    Locations
    41 in total
    Run by
    Medical University of South Carolina

    See if you can join NCT06289985 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.